| 1 |
Siegel Rl, Miller KD. Cancer statistics, 2018[J]. CA Cancer J Clin, 2018, 68(1): 7-30.
|
| 2 |
Qin JB, Ning HC, Zhao Y, et al. LncRNA MIR31HG overexpression serves as poor prognostic biomarker and promotes cells proliferation in lung adenocarcinoma[J]. Biomed Pharmacoth, 2018, 99: 363-368.
|
| 3 |
Li J, Li Z, Zheng W, et al. Lncrna-atb: an indispensable cancer-related long noncoding rna[J]. Cell Prolif, 2017, 50(6): doi: 10.1111/cpr.12381. |
| 4 |
Peng W, He D, Shan B, et al. LINC81507 act as a competing endogenous RNA of miR-199b-5p to facilitate NSCLC proliferation and metastasis via regulating the CAV1/STAT3 pathway[J]. Cell Death Dis, 2019, 10: 533.
|
| 5 |
Ji NN, Wang YH, Bao BL, et al. LncRNA SNHG14 promotes the progression of cervical cancer by regulating miR-206/YWHAZ[J]. Pathol Res Pract, 2019, 215(4): 668-675.
|
| 6 |
Huo HC, Tian J, Wang RY, et al. Long non-coding RNA NORAD upregulate SIP1 expression to promote cell proliferation and invasion in cervical cancer[J]. Biomed Pharmacother, 2018, 106: 1454-1460.
|
| 7 |
Williamson PR, Smith CT, Hutton JL, et al. Aggregate data meta-analysis with time-to-event outcomes[J]. Stat Med, 2002, 21: 3337-3351.
|
| 8 |
Tierney JF, Stewart LA, Ghersi D, et al. Practical methods for incorporating summary time-to-event data into meta-analysis[J]. Trials, 2007, 8: 16.
|
| 9 |
Stang A. Critical evaluation of Newcastle-Ottawa scale for sessment of the quality of nonrandomized studies in meta-analyses[J]. Eur JEpidemiol, 2010, 25(9): 603-605.
|
| 10 |
DerSimonian R, Kacker R. Random-effects model for meta-analysis of clinical trials: an update[J]. Contemp Clin Trials, 2007, 28: 105-114.
|
| 11 |
Han W, Du XM, Wang J, et al. SNHG16 indicates a poor prognosis and affects cell proliferation, migration and invasion in non-small cell lung cancer[J]. Exp Cell Res, 2017, Sep 19.
|
| 12 |
Lin Q, Zheng HG, Xu JJ, et al. LncRNASNHG16 aggravates tumorigenesis and development of hepatocellular carcinoma by sponging miR-4500andtargetingSTAT3[J]. J Cell Biochem, 2019, doi: 10.1002/jcb.28440. |
| 13 |
Zhu H, Zeng Y, Zhou CC, et al. SNHG16/miR-216-5p/ZEB1 signal pathway contributes to the tumorigenesis of cervical cancer cells[J]. Arch.Biochem.Biophys, 2018, 1: 637.
|
| 14 |
Han W, Du XM, Liu M, et al. Increased expression of long non-coding RNA SNHG16 correlates with tumor progression and poor prognosis in nonsmall cell lung cancer[J]. Int J Biol Macromol, 2019, 121: 270-278.
|
| 15 |
Li YL, Lu Y, Chen YL, et al. Long non-coding RNA SNHG16 affects cell proliferation and predicts a poor prognosis in patients with colorectal cancer via sponging miR-200a-3p[J]. Biosci Rep, 2019, 39(5): doi: 10.1042/BSR20182498. |
| 16 |
Liao SA, Xing SX, Ma YH, et al. LncRNA SNHG16 sponges miR-98-5p to regulate cellular processes in osteosarcoma[J]. Cancer Chemother Pharmacol, 2019, 83(6): 1065-1074.
|
| 17 |
Liu SY, Zhang W, Liu K, et al. LncRNA SNHG16 promotes tumor growth of pancreatic cancer by targeting miR-218-5p[J]. Biomed Pharmacother, 2019, 114: 108862.
|
| 18 |
Lu YF, Cai XL, Li ZZ, et al. LncRNA SNHG16 Functions as an Oncogene by Sponging MiR-4518 and UpRegulating PRMT5 Expression in Glioma[J]. Cell Physiol Biochem, 2018, 45: 1975-1985.
|
| 19 |
Wang XL, Hu KJ, Chao Y, et al. LncRNA SNHG16 promotes proliferation，migration and invasion of osteosarcoma cells by targeting miR-1301/BCL9 axis[J]. Biomed Pharmacother, 2019, 114: 108798.
|
| 20 |
Zhong JH, Xiang X, Wang YY, et al. The lncRNA SNHG16 affects prognosis in hepatocellular carcinoma by regulating p62 expression[J]. J Cell Physiol, 2020, 235(2): 1090-1102.
|
| 21 |
Cao XX, Jing Xu J, Yue D, et al. LncRNA-SNHG16 predicts poor prognosis and promotes tumor proliferation through epigenetically silencing p21 in bladder cancer[J]. Cancer Gene Ther, 2018, 25(1-2): 10-17.
|
| 22 |
Guo ZL, Zhang J, Fan LL, et al. Long Noncoding RNA (lncRNA) Small Nucleolar RNA Host Gene 16 (SNHG16) Predicts Poor Prognosis and Sorafenib Resistance in Hepatocellular Carcinoma[J]. Med Sci Monit, 2019, 25: 2079-2086.
|
| 23 |
Han GH, Lu KJ, Wang P, et al. LncRNA SNHG16 predicts poor prognosis in ESCC and promotes cell proliferation and invasion by regulating Wnt/β-catenin signaling pathway[J]. Eur Rev Med Pharmacol Sci, 2018, 22(12): 3795-3803.
|
| 24 |
Yang XS, Wang GX, Luo L, et al. Long non-coding RNA SNHG16 promotes cell growth and metastasis in ovarian cancer[J]. Eur Rev Med Pharmacol Sci, 2018, 22(3): 616-622.
|
| 25 |
马秦榕，魏亚敏，傅仁秀，等. LncRNA SNHG12、SNHG15及SNHG16在肺腺癌的表达及意义[J]. 诊断病理学杂志，2019, 26(5): 278-282.
|
| 26 |
周云松，温小辉，张 琦，等. lncRNASNHG16在结直肠癌组织和细胞中表达及其调控结肠癌细胞中GPAM表达的机制[J]. 中国肿瘤生物治疗杂志，2019, 26(1): 58-66.
|
| 27 |
Peng H, Li H. The encouraging role of long non codingRNA small nuclear RNA host gene 16 in epithelial-mesenchymal transitionof bladder cancer via directly acting on miR-17-5p/metalloproteinases 3axis[J]. Molecular Carcinogenesis, 2019: 1-16.
|
| 28 |
Xu Y, Qiu M, Chen Y, et al. Long noncoding RNA, tissue differentiation-inducing nonprotein coding RNA is upregulated and promotes development of esophageal squamous cell carcinoma[J]. Diseases of the Esophagus, 2017, 30: 1-10.
|
| 29 |
Sun Y, Jin SD, Zhu Q, et al. Long non-coding RNA LUCAT1 is associated with poor prognosis in human non-small cell lung cancer and regulates cell proliferation via epigenetically repressing p21 and p57 expression[J]. Oncotarget, 2017, 8(17): 28297-28311.
|
| 30 |
Yan SY, Tang ZR, Chen K, et al. Long noncoding RNA MIR31HG inhibits hepatocellular carcinoma proliferation and metastasis by sponging microRNA-575 to modulate ST7L expression[J]. J Experimen Clin Cancer Res, 2018, 37: 214.
|
| 31 |
Wang R, Ma ZH, Feng L, et al. LncRNA MIR31HG targets HIF1A and P21 to facilitate head and neck cancer cell proliferation and tumorigenesis by promoting cell-cycle progression[J]. Molecular Cancer, 2018, 17: 162.
|
| 32 |
Li W, W. Xu W, Song JS, et al. LncRNA SNHG16 promotes cell proliferation through miR-302a-3p/FGF19 axis in hepatocellular carcinoma[J]. Neoplasma, 2019, 66(3): 397-404.
|
| 33 |
Liu YH, Zhou JY, Wang SL, et al. Long non coding RNA SNHG12 promotes proliferation and invasion of colorectal cancer cells by acting as a molecular sponge of microRNA 16[J]. Exp Ther Med, 2019, 18(2): 1212-1220.
|
| 34 |
钱桂生. 肺癌不同病理类型发病率的变化情况及其原因[J/CD]. 中华肺部疾病杂志(电子版), 2011, 4(1): 1-5.
|